Overview
Maskeliya Plantations' audited FY2026 profit weakened despite higher revenue, making the durability of tea estate margins the central issue. The company cultivates, manufactures and markets black tea from 18 estates, alongside smaller timber and high-value crop activities.
Price performance
The share fell 15.1% over three months, versus a 4.5% fall in the ASPI, and closed at LKR62.00 on 1 September 2026. It was at the bottom of its 52-week range, while the 20-day average volume was 63.3% above its 60-day norm.
Sixty-day annualised volatility was below the stock's own one-year norm. The supplied company news flow and filings do not account for the three-month share-price decline.
Valuation
At 5.25 times earnings, MASK sits in the cheapest 5% of the plantation peer set. Its 1.07 times book value is around the sector middle, while FY2026 ROE of 22.2% provides support for trading close to book value.
The 6.5% yield is near the top of the sector distribution. Dividends recorded for FY2026 were LKR4.00 per share, after LKR4.50 in FY2025; the latest year may be incomplete, so this does not establish a final payout cut.
News and sentiment
Direct coverage is thin, with no material company articles recorded in the past 90 days and therefore no positive or negative sentiment split to assess.
The last disclosed company item was a LKR4.00 first interim dividend for FY2026, which went ex on 10 April 2026 and was paid on 30 April 2026.
Financials
The June 2026 quarter was filed on a company basis, while the June 2025 comparator was filed on a group basis, so a year-on-year comparison is not like-for-like. Gross margin was 17.6%, operating margin 13.8% and net margin 9.3%; each was the weakest in the available comparable June record.
Below-the-line items absorbed LKR74 million of operating profit in the quarter. In the audited year ended March 2026, revenue grew 5.0% but net profit fell 31.3%, showing that higher sales did not translate into higher shareholder earnings. Equity increased to LKR3.12 billion, while the share count was effectively unchanged.
Risks
The main operating risk is tea-market weakness: sector tea export earnings fell 17.2% in July amid shipping disruption and weaker dollar realisations. That backdrop does not describe Maskeliya specifically, but it is relevant to a tea-focused operator whose June margins were the weakest in its comparable June record.
Balance-sheet risk is materially lower than a year earlier, with no reported debt at March 2026, a current ratio of 1.45 and interest cover of 10.62 times. However, cash conversion was 0.81 times operating profit in FY2026, so reported earnings were not fully realised as operating cash.
Outlook
As at 1 September 2026, the next defined catalyst is the September 2026 quarterly filing, expected between 11 November 2026 and 27 February 2027. It will show whether the weak June margin record persisted after the latest filed period.
The available data cannot establish Maskeliya's realised tea prices, production volumes or the company-specific effect of weaker national tea exports.